AMBQ Form 4: CFO award of 83,819 RSUs increases ownership to 132,818
Rhea-AI Filing Summary
Hanson Scott McLean, who serves as Chief Financial Officer and a director of Ambiq Micro, Inc. (AMBQ), received a grant of $0-priced restricted stock units totaling 83,819 RSUs on 10/02/2025. Each RSU converts into one share of common stock upon settlement. After the grant, the reporting person beneficially owns 132,818 shares in total. The RSUs vest 25% on 10/01/2026 with the remainder vesting in equal quarterly installments of 1/12 thereafter, subject to continued service under the 2025 Equity Incentive Plan. The grant was reported on the Form 4 filed and signed by an attorney-in-fact on 10/06/2025.
Positive
- Substantial time‑based equity grant of 83,819 RSUs supports executive retention
- Post‑grant ownership of 132,818 shares increases executive alignment with shareholders
Negative
- Potential dilution when 83,819 RSUs vest and settle, increasing outstanding shares
- Vesting contingent on continued service, so value is forfeitable if employment ends before vesting
Insights
Grant aligns CFO incentives with shareholder value through time‑based RSUs.
The award of 83,819 RSUs is a time‑based equity grant that vests 25% after one year and then quarterly, encouraging retention and long‑term alignment with shareholders. The zero strike price indicates these are restricted stock units rather than options, which transfer full share value on settlement.
The main dependency is continued service; vesting is subject to the executive remaining employed. Watch for future disclosures when RSUs settle, which will increase outstanding shares and could modestly dilute existing holders; monitor outstanding share counts in the next 12–36 months.
The grant increases potential share count and immediate beneficial ownership to 132,818 shares.
The reported post‑grant beneficial ownership of 132,818 shares reflects the reporting person’s current and contingent equity holdings. Settlement of the 83,819 RSUs will add shares to the float when they vest and are issued.
Monitor quarterly filings and the company’s share count disclosures over the next 12–36 months to quantify dilution impact and compare new shares against current outstanding shares to assess materiality.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 83,819 | $0.00 | -- |
Footnotes (1)
- [object Object]